Early refractive outcome after intravitreous bevacizumab for retinopathy of prematurity
Retinopathy of prematurity (ROP) is a neovascular retinal disease that has usually been treated by peripheral argon laser coagulation. Retinal laser coagulation has disadvantages and adverse effects such as the need for general anesthesia, scarring of the peripheral retina and choroid, and...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) Editorial |
| Sprache: | Englisch |
| Veröffentlicht: |
2012
|
| In: |
Archives of ophthalmology
Year: 2012, Jahrgang: 130, Heft: 6, Pages: 800-801 |
| ISSN: | 1538-3601 |
| DOI: | 10.1001/archophthalmol.2012.1 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1001/archophthalmol.2012.1 Verlag, kostenfrei, Volltext: https://jamanetwork.com/journals/jamaophthalmology/fullarticle/1182272 
|
| Verfasserangaben: | Bjoern C. Harder, MD, Stefan von Baltz, MD, Frank C. Schlichtenbrede, MFD, Jost B. Jonas, MD |
| Zusammenfassung: | Retinopathy of prematurity (ROP) is a neovascular retinal disease that has usually been treated by peripheral argon laser coagulation. Retinal laser coagulation has disadvantages and adverse effects such as the need for general anesthesia, scarring of the peripheral retina and choroid, and... |
|---|---|
| Beschreibung: | Gesehen am 07.08.2018 |
| Beschreibung: | Online Resource |
| ISSN: | 1538-3601 |
| DOI: | 10.1001/archophthalmol.2012.1 |